China Spinal Cord Injury Network   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Hong Kong Hong Kong (2006)

Organization Overview

First Clinical Trial
2007
NCT00431171
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

China Spinal Cord Injury Network

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 1)

Anemia, Neonatal (Phase 1)

Brain Diseases (Phase 1)

Brain Ischemia (Phase 1)

Cerebral Infarction (Phase 1)

Hypoxia (Phase 1)

Hypoxia-Ischemia, Brain (Phase 1)

Ischemia (Phase 1)

Neuralgia (Phase 2)

Spinal Cord Injuries (Phase 2)

Stroke (Phase 1)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 8
  • # of Trial APIs: 5